Humanized B-B10
US5886152A · kind A · utility
152Cited by
3References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 10, 1994 |
| Grant date | Mar 23, 1999 |
| Priority date | — |
| Expiry date | May 10, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A humanized antibody is provided, which is obtained by transplantation of the complementarity determining region of a mouse monoclonal antibody B-B10 specific to a human IL-2 receptor into a human antibody. The antibody has a very low antigenicity, and therefore, it is useful for treatment of carcinoma expressing IL-2 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.